Lv2
110 积分 2022-12-05 加入
Synthesizability via reward engineering: expanding generative molecular design into synthetic space
10天前
已完结
Data-centric challenges with the application and adoption of artificial intelligence for drug discovery
10天前
已完结
Bridging data and drug development: Machine learning approaches for next-generation ADMET prediction
11天前
已完结
Strategic Use of the Necessary Nitrogen Atom for Holistic Property-Based Drug Design
2个月前
已完结
Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs
3个月前
已完结
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
3个月前
已完结
Discovery of Novel Isoxazole-Based FXR Agonists Containing a 1,2,4-Oxadiazol-5(4H)-one Ring
3个月前
已完结
In Silico ADMET: From Current Practices to Novel Profilers
3个月前
已完结
Exploring Privileged Structure Repurposing: Target Similarity as a Catalyst for Cross-Species Drug Discovery
3个月前
已完结
Recent Advances in Targeting RNA Splicing Factors with Small Molecules
3个月前
已完结
皖公网安备34019202002308
